Received Jan 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 4 | JB4K2 | IM / LA |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | MB599 | IM / LA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 3 | Y015989 | IM / RA |
Patient's mother stated that immigration required the patient to be revaccinated due to lack of immunity, per blood work, even though vaccines were previously received in the [withheld] and in [withheld]. Patient should have received MMR. Patient received MMRV. No adverse symptoms or signs observed or reported by patient or patient's mother.
None disclosed
None disclosed
None disclosed
None disclosed